Trial · NCT01291173
Results by group128
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 128
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Log Transformed Binge Days Per Week at Week 11 | Placebo | -1.23 | Standard Error 0.069 | Log days | |
| Change From Baseline in Log Transformed Binge Days Per Week at Week 11 | Lisdexamfetamine Dimesylate (SPD489) 30 mg | -1.24 | Standard Error 0.067 | Log days | |
| Change From Baseline in Log Transformed Binge Days Per Week at Week 11 | Lisdexamfetamine Dimesylate (SPD489) 50 mg | -1.49 | Standard Error 0.066 | Log days | |
| Change From Baseline in Log Transformed Binge Days Per Week at Week 11 | Lisdexamfetamine Dimesylate (SPD489) 70 mg | -1.57 | Standard Error 0.067 | Log days | |
| Change From Baseline in the Number of Binge Episodes Per Week at Up to 11 Weeks | Placebo | -4.07 | Standard Deviation 2.718 | Binge Episodes | |
| Change From Baseline in the Number of Binge Episodes Per Week at Up to 11 Weeks | Lisdexamfetamine Dimesylate (SPD489) 30 mg | -4.57 | Standard Deviation 3.266 | Binge Episodes | |
| Change From Baseline in the Number of Binge Episodes Per Week at Up to 11 Weeks | Lisdexamfetamine Dimesylate (SPD489) 50 mg | -5.10 | Standard Deviation 3.026 | Binge Episodes | |
| Change From Baseline in the Number of Binge Episodes Per Week at Up to 11 Weeks | Lisdexamfetamine Dimesylate (SPD489) 70 mg | -5.09 | Standard Deviation 2.586 | Binge Episodes | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Placebo | 1 week remission | 23 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 30 mg | 1 week remission | 28 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 50 mg | 1 week remission | 33 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 70 mg | 1 week remission | 35 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Placebo | Marked response | 15 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 30 mg | Marked response | 20 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 50 mg | Marked response | 24 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 70 mg | Marked response | 23 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Placebo | Moderate response | 13 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 30 mg | Moderate response | 8 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 50 mg | Moderate response | 4 | Participants | |
| 1-Week Binge Response, Last Observation Carried Forward (LOCF) | Lisdexamfetamine Dimesylate (SPD489) 70 mg | Moderate response | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01291173/results